49 related articles for article (PubMed ID: 10491771)
1. Report of a 1998 EASD-Bayer travel fellowship for Young scientists. Effect of oxidized LDL and glucose in tyrosine kinase receptors.
Portero-Otin M
Diabetologia; 1999 Aug; 42(8):37-8. PubMed ID: 10491771
[No Abstract] [Full Text] [Related]
2. Report from a member awarded an EASD-Bayer Travel Fellowship for Young Scientists 1997.
Weyer C
Diabetologia; 1997 Dec; 40(12):suppl 45-6. PubMed ID: 9447941
[No Abstract] [Full Text] [Related]
3. Low density lipoproteins transactivate EGF receptor: role in mesangial cell proliferation.
Kamanna VS; Bassa BV; Ganji SH
Life Sci; 2008 Oct; 83(17-18):595-601. PubMed ID: 18805430
[TBL] [Abstract][Full Text] [Related]
4. Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.
Song L; Turkson J; Karras JG; Jove R; Haura EB
Oncogene; 2003 Jul; 22(27):4150-65. PubMed ID: 12833138
[TBL] [Abstract][Full Text] [Related]
5. S-Nitrosylation of the epidermal growth factor receptor: a regulatory mechanism of receptor tyrosine kinase activity.
Murillo-Carretero M; Torroglosa A; Castro C; Villalobo A; Estrada C
Free Radic Biol Med; 2009 Feb; 46(4):471-9. PubMed ID: 19056486
[TBL] [Abstract][Full Text] [Related]
6. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
Actis Dato SM; Rebolledo OR
Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
[TBL] [Abstract][Full Text] [Related]
7. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Mehta JL
Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
[TBL] [Abstract][Full Text] [Related]
8. Report on EFSD/MSD Travel Fellowship for Young Scientists 2001. % week stay at the MRC Phosphorylation Unit, University of Dundee.
Göransson O
Diabetologia; 2002 Jun; 45(6):R30. PubMed ID: 12154778
[No Abstract] [Full Text] [Related]
9. Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus.
Garrido-Sánchez L; Cardona F; García-Fuentes E; Rojo-Martínez G; Gómez-Zumaquero JM; Picón MJ; Soriguer F; Tinahones FJ
Eur J Clin Invest; 2008 Sep; 38(9):615-21. PubMed ID: 18837736
[TBL] [Abstract][Full Text] [Related]
10. Transactivation: a novel signaling pathway from angiotensin II to tyrosine kinase receptors.
Saito Y; Berk BC
J Mol Cell Cardiol; 2001 Jan; 33(1):3-7. PubMed ID: 11133218
[TBL] [Abstract][Full Text] [Related]
11. Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function.
Mukherjee S; Tessema M; Wandinger-Ness A
Circ Res; 2006 Mar; 98(6):743-56. PubMed ID: 16574915
[TBL] [Abstract][Full Text] [Related]
12. Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.
Welin S; Fjällskog ML; Saras J; Eriksson B; Janson ET
Neuroendocrinology; 2006; 84(1):42-8. PubMed ID: 17047316
[TBL] [Abstract][Full Text] [Related]
13. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
14. Structural changes of low density lipoproteins with Cu2+ and glucose induced oxidation.
Gallego-Nicasio J; López-Rodríguez G; Martínez R; Tarancón MJ; Fraile MV; Carmona P
Biopolymers; 2003; 72(6):514-20. PubMed ID: 14587073
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinases as mediators of injury-induced bradykinin B1 receptor expression in rabbit aortic smooth muscle.
Koumbadinga GA; Petitclerc E; Bouthillier J; Adam A; Marceau F
Eur J Pharmacol; 2009 Mar; 606(1-3):233-9. PubMed ID: 19374866
[TBL] [Abstract][Full Text] [Related]
16. Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.
Ali TK; Matragoon S; Pillai BA; Liou GI; El-Remessy AB
Diabetes; 2008 Apr; 57(4):889-98. PubMed ID: 18285558
[TBL] [Abstract][Full Text] [Related]
17. Report for the EASD-Bayer Travel Fellowship for Young Scientist 1997. European Association of the Study of Diabetes.
Jones SM
Diabetologia; 1998 Mar; 41(3):20. PubMed ID: 9541183
[No Abstract] [Full Text] [Related]
18. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
Miao H; Wei BR; Peehl DM; Li Q; Alexandrou T; Schelling JR; Rhim JS; Sedor JR; Burnett E; Wang B
Nat Cell Biol; 2001 May; 3(5):527-30. PubMed ID: 11331884
[TBL] [Abstract][Full Text] [Related]
19. Receptor association and tyrosine phosphorylation of S6 kinases.
Rebholz H; Panasyuk G; Fenton T; Nemazanyy I; Valovka T; Flajolet M; Ronnstrand L; Stephens L; West A; Gout IT
FEBS J; 2006 May; 273(9):2023-36. PubMed ID: 16640565
[TBL] [Abstract][Full Text] [Related]
20. Cellular adhesion of primary Sertoli cells affects responsiveness of the extracellular signal-regulated kinases 1 and 2 to follicle-stimulating hormone but not to epidermal growth factor.
Crépieux P; Martinat N; Marion S; Guillou F; Reiter E
Arch Biochem Biophys; 2002 Mar; 399(2):245-50. PubMed ID: 11888212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
